Home > Insider Trading > Filing (0001225208-17-016298)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
9892	Bard C R Inc	BCR	Surgical & Medical Instruments & Apparatus (3841)	221454160

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1462450	P Timothy Collins	C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974	Group President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-10-12	23,910	$97.69	50,556	No	4	M	Direct
Common Stock	Acquisiton	2017-10-12	17,832	$136.37	68,388	No	4	M	Direct
Common Stock	Acquisiton	2017-10-12	9,418	$168.87	77,806	No	4	M	Direct
Common Stock	Acquisiton	2017-10-12	4,390	$186.43	82,196	No	4	M	Direct
Common Stock	Acquisiton	2017-10-12	268	$84.58	82,464	No	4	M	Direct
Common Stock	Disposition	2017-10-12	55,818	$322.03	26,646	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (Right to Buy)	Disposition	2017-10-12	4,390	$0.00	4,390	$186.43
Common Stock	Option (Right to Buy)	Disposition	2017-10-12	9,418	$0.00	9,418	$168.87
Common Stock	Option (Right to Buy)	Disposition	2017-10-12	17,832	$0.00	17,832	$136.37
Common Stock	Option (Right to Buy)	Disposition	2017-10-12	23,910	$0.00	23,910	$97.69
Common Stock	Option (Right to Buy)	Disposition	2017-10-12	268	$0.00	268	$84.58

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,172	2025-12-09	No	4	M	Direct
9,419	2024-12-10	No	4	M	Direct
5,944	2023-12-11	No	4	M	Direct
0	2022-12-12	No	4	M	Direct
0	2021-12-14	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	356	Indirect	401(k) Plan

Footnotes

Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
Represents the weighted average sales price for price increments ranging from $322.00 to $322.16. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Of this option grant 4,390 options fully vested and the remaining options vest in three annual installments beginning on December 9, 2017.
Of this option grant 9,418 options fully vested and the remaining options vest in two annual installments beggining on December 10, 2017.
Of this option grant 17,832 options fully vested and the remaining options vest on December 11, 2017.
Options fully vested and are currently exercisable.
Options granted under 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).